IDP-126 clinical trials
How each study uses IDP-126 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses IDP-126 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle GelCompletedPhase 2Bausch Health Americas, Inc.NCT04892706Written as IDP-126 Gel
- Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne VulgarisCompletedPhase 3Bausch Health Americas, Inc.NCT04214639Written as IDP-126 Gel
- Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne VulgarisCompletedPhase 3Bausch Health Americas, Inc.NCT04214652Written as IDP-126 Gel
- A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne VulgarisCompletedPhase 2Bausch Health Americas, Inc.NCT03170388Written as IDP-126 Gel
- Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control GelCompletedPhase 1Bausch Health Americas, Inc.NCT03653403Written as IDP-126 Gel